EDS clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • HBS-301 in Participants With Narcolepsy

    Sorry, not currently recruiting here

    This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in treating excessive daytime sleepiness (EDS), cataplexy, sleepiness/wakefulness, and fatigue in adult participants (ages ≥18 years) with narcolepsy.

    at UCSF

Our lead scientists for EDS research studies include .

Last updated: